This week's roundup of Houston innovators includes Jessica Traver Ingram of IntuiTap, Kelsey Ruger of Hello Alice, Katy Rezvani of MD Anderson Cancer Center. Photos courtesy

Editor's note: Every week, I introduce you to three Houston innovators to know recently making headlines with news of innovative technology, investment activity, and more. This week's batch includes a podcast with a health tech founder, advice from an AI expert, and a cancer-fighting innovator.

Jessica Traver Ingram, CEO and co-founder of IntuiTap

Jessica Traver Ingram, CEO and co-founder of IntuiTap, joins the Houston Innovators Podcast to share her company's latest milestone. Photo courtesy of IntuiTap

Jessica Traver Ingram has been captivated by the intersection of physics and health care for most of her life, and that passion led her to contributing to the establishment of the Texas Medical Center's Biodesign Fellowship. After helping make the program a reality, Traver Ingram then participated in it as a fellow.

The program selects fellows and then lets them explore the TMC's member institutions to find ways to innovate within unmet clinical needs, and the inefficiency and challenges with placing epidurals and lumbar punctures caught Traver Ingram and her cohort's eye. The process relies completely on the health care practitioner's ability to feel the spine with their fingers to make the injection.

"We kept watching the inefficiencies of these procedures, and everyone was like, 'you're right, we don't really know why we do it this way,'" Traver Ingram says on the Houston Innovators Podcast. "It's really cool to be outsiders watching and observing, because you just see things other people don't see — and that's in any industry."

With that, IntuiTap was born. Traver Ingram describes its tool, the VerTouch, as a "stud finder for the spine." After years of growing the company, she can also now call it FDA-approved. Read more.


Kelsey Ruger, chief technology and product officer for Hello Alice

AI's true potential lies in its ability to enhance human capabilities, not replace them. Photo courtesy

Ready or not, artificial intelligence is coming. In fact, it's already affecting the workforce.

"With its ability to automate tasks, analyze large amounts of data, and provide detailed insights, AI offers an enormous opportunity for businesses of all sizes," writes Kelsey Ruger, chief technology and product officer for Hello Alice, in a guest column. "However, realizing this potential requires a strategic approach that positions AI as a powerful partner, rather than a replacement for human ingenuity."

Ruger shares how business can unlock AI's full potential via automation, augmentation, and autonomy. Read more.

Katy Rezvani, professor of stem cell transplantation and cellular therapy at MD Anderson Cancer Center

At Rezvani Lab in MD Anderson Cancer Center, scientists train immune cells to fight cancer. Photo courtesy

San Diego-based Replay incorporated a first-in-class engineered TCR-NK cell therapy product company, Syena, using technology developed by Dr. Katy Rezvani at The University of Texas MD Anderson Cancer Center. The company has announced that its first patient has been dosed with an engineered T-Cell Receptor Natural Killer (TCR-NK) cell therapy for relapsed or refractory multiple myeloma.

Rezvani, a professor of stem cell transplantation and cellular therapy, is the force behind MD Anderson’s Rezvani Lab, a group of 55 people, all focused on harnessing natural killer cells to combat cancer.

“Everybody thinks that the immune system is fighting viruses and infections, but I feel our immune system is capable of recognizing and killing abnormal cells or cells that are becoming cancerous and they're very powerful. This whole field of immunotherapy really refers to the power of the immune system,” Rezvani tells InnovationMap. Read more.

AI's true potential lies in its ability to enhance human capabilities, not replace them. Photo via Getty Images

Houston expert shares 3 strategies for integrating AI into the workforce

guest column

The rapid advancement of artificial intelligence is forcing businesses to evaluate how they will manage the inevitable changes this technology will bring. With its ability to automate tasks, analyze large amounts of data, and provide detailed insights, AI offers an enormous opportunity for businesses of all sizes. However, realizing this potential requires a strategic approach that positions AI as a powerful partner, rather than a replacement for human ingenuity.

The British Council reports that an estimated 65 percent of today's students will eventually work in professions that have yet to be conceived. With the emergence of new AI, this projection emphasizes the importance of cultivating a versatile skill set that allows us to adapt to the ever-changing landscape. It also underscores the importance of having a strategy that embraces the division of labor between humans and machines.

What this means is that an AI strategy shouldn't just be about automation – it should also incorporate an understanding of the human-AI partnership that will be necessary for future success. By using the concepts of automation, augmentation, and autonomy, businesses can unlock the full potential of AI to boost efficiency, enhance decision-making, and ultimately drive continued success.

Automation: Delegating to the AI

We know AI can automate many tasks in a business. However, we should also look at automation from a strategy standpoint by asking, "What tasks can be fully delegated to the AI?" Answering this question might include considering routine, repetitive, and time-consuming tasks that shouldn't require human intervention or those that would be more susceptible to human error. The goal here should be to identify tasks that don't benefit from human nuance, meaning asking questions about time, precision, and compliance could offer even more value.

  • Time. What tasks are time-consuming and could be completed quickly with well-written instructions?
  • Precision. What tasks require precision that is difficult for humans to achieve?
  • Compliance. What tasks involve critical safety procedures or adherence to strict compliance that humans might overlook?

Augmentation: Using AI to boost your potential

Beyond automation, AI's true power lies in its ability to boost human capabilities. In this lens, you should ask, "How can the AI boost my output potential?" Think of AI as a skilled assistant that can analyze vast datasets, identify complex patterns, and present insights that aren't readily apparent to humans alone. The focus here is on tasks that still require a human touch but can benefit from computers' speed and data processing power. When exploring this further, consider asking questions about skill boosts, assistance, and focus.

  • Skill boosts. What tasks am I doing that I understand but need to be an expert at?
  • Assistance. What tasks still require a human's touch but could use processing or speed boosts?
  • Focus. What tasks are causing employees to spend more time on tools and less on goals?

Autonomy: The importance of humans in the loop

One question that comes up frequently when discussing AI is whether it will replace a particular set of jobs. My thoughts, however, are that while AI is remarkably powerful, the key to making all this work is understanding that not every task requires automation. In fact, some tasks would suffer from automation. This step requires you to ask, "Where are human emotion, creativity, intuition, and oversight essential?" Autonomy, in this sense, means digging into creativity, intuition, and uniqueness.

  • Creativity. Does this task require a level of creativity that a machine can't replicate?
  • Intuition. Does this task require emotional awareness that a machine can't discern?
  • Brand Uniqueness. Does this task represent a part of my brand that shouldn't be automated or machine-driven?

AI brings a lot to look forward to. It’s fair to say it’s on its way to transforming the world, but it's important to remember that the businesses that strategically embrace a human-centered approach to integrating AI into everyday business activities are the ones that will thrive. The three A’s: automation, augmentation, and autonomy, provide an essential foundation to begin this journey. By understanding the best applications for each aspect of AI, businesses of all sizes can discover areas for increased efficiency, more thoughtful decision-making, and a competitive edge that drives long-term success. AI's true potential lies in its ability to enhance human capabilities, not replace them.

------

Kelsey Ruger is the chief technology and product officer for Hello Alice.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”